Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment services; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients. The Agilent CrossLab segment offers GC and LC columns, sample preparation products, custom chemistries, and various laboratory instrument supplies; and startup, operational, training, and compliance support, as well as asset management and consultation services. The company markets its products through direct sales, electronic commerce, resellers, manufacturers' representatives, and distributors. It has collaboration with the University of Southern California Michelson Center for Convergent Bioscience. Agilent Technologies, Inc. was founded in 1999 and is headquartered in Santa Clara, California.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
Current SymbolNYSE:A
Previous Symbol
CUSIP00846U10
Phone408-345-8886
Debt
Debt-to-Equity Ratio0.39
Current Ratio3.29
Quick Ratio2.74
Price-To-Earnings
Trailing P/E Ratio24.86
Forward P/E Ratio22.82
P/E Growth2.01
Sales & Book Value
Annual Sales$4.91 billion
Price / Sales4.50
Cash Flow$3.3867 per share
Price / Cash Flow20.48
Book Value$14.34 per share
Price / Book4.84
Profitability
EPS (Most Recent Fiscal Year)$2.79
Net Income$316 million
Net Margins6.43%
Return on Equity19.84%
Return on Assets10.56%
Miscellaneous
Employees13,500
Outstanding Shares318,770,000
Market Cap$22.87 billion
OptionableOptionable
Agilent Technologies (NYSE:A) Frequently Asked Questions
What is Agilent Technologies' stock symbol?
Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."
How often does Agilent Technologies pay dividends? What is the dividend yield for Agilent Technologies?
Agilent Technologies announced a quarterly dividend on Wednesday, November 14th. Shareholders of record on Monday, December 31st will be given a dividend of $0.164 per share on Wednesday, January 23rd. This represents a $0.66 annualized dividend and a yield of 0.95%. The ex-dividend date of this dividend is Friday, December 28th. This is an increase from Agilent Technologies's previous quarterly dividend of $0.15. View Agilent Technologies' Dividend History.
How will Agilent Technologies' stock buyback program work?
Agilent Technologies declared that its board has authorized a share repurchase plan on Monday, November 19th 2018, which permits the company to repurchase $1,750,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to repurchase up to 8.8% of its shares through open market purchases. Shares repurchase plans are often an indication that the company's board believes its stock is undervalued.
How were Agilent Technologies' earnings last quarter?
Agilent Technologies Inc (NYSE:A) posted its quarterly earnings results on Monday, November, 19th. The medical research company reported $0.81 EPS for the quarter, beating analysts' consensus estimates of $0.74 by $0.07. The medical research company had revenue of $1.29 billion for the quarter, compared to the consensus estimate of $1.26 billion. Agilent Technologies had a return on equity of 19.84% and a net margin of 6.43%. Agilent Technologies's revenue was up 8.8% on a year-over-year basis. During the same period last year, the business posted $0.67 EPS. View Agilent Technologies' Earnings History.
When is Agilent Technologies' next earnings date?
What guidance has Agilent Technologies issued on next quarter's earnings?
Agilent Technologies updated its FY19 earnings guidance on Monday, November, 19th. The company provided earnings per share (EPS) guidance of $3.00-3.05 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.97. The company issued revenue guidance of $5.13-5.17 billion, compared to the consensus revenue estimate of $5.19 billion.Agilent Technologies also updated its FY 2019 guidance to $3.00-3.05 EPS.
What price target have analysts set for A?
9 brokers have issued 1 year target prices for Agilent Technologies' shares. Their predictions range from $74.00 to $89.00. On average, they anticipate Agilent Technologies' share price to reach $79.4286 in the next twelve months. This suggests a possible upside of 14.5% from the stock's current price. View Analyst Price Targets for Agilent Technologies.
What is the consensus analysts' recommendation for Agilent Technologies?
9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 1 hold rating and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Agilent Technologies.
Has Agilent Technologies been receiving favorable news coverage?
Media coverage about A stock has trended somewhat positive on Friday, according to InfoTrie. InfoTrie rates the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Agilent Technologies earned a daily sentiment score of 1.2 on InfoTrie's scale. They also assigned press coverage about the medical research company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the next few days.
Who are some of Agilent Technologies' key competitors?
Some companies that are related to Agilent Technologies include Illumina (ILMN), Mettler-Toledo International (MTD), Waters (WAT), PerkinElmer (PKI), Bio-Rad Laboratories (BIO), Bio-Rad Laboratories (BIO.B), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Pacific Biosciences of California (PACB), Accelerate Diagnostics (AXDX), Quanterix (QTRX), Fluidigm (FLDM), Eyepoint Pharmaceuticals (EYPT) and Harvard Bioscience (HBIO).
Who are Agilent Technologies' key executives?
Agilent Technologies' management team includes the folowing people:
- Mr. Michael R. McMullen, CEO, Pres & Director (Age 57)
- Mr. Mark Doak, Sr. VP & Pres of Agilent CrossLab Group (Age 63)
- Mr. Jacob Thaysen, Sr. VP and Pres of Life Sciences & Applied Markets Group (Age 43)
- Mr. Robert W. McMahon, Sr. VP & CFO (Age 49)
- Mr. Rodney Gonsalves, Chief Accounting Officer, VP & Corp. Controller (Age 52)
Who are Agilent Technologies' major shareholders?
Agilent Technologies' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (8.15%), Vanguard Group Inc (7.58%), OppenheimerFunds Inc. (2.69%), FMR LLC (2.13%), American Century Companies Inc. (1.68%) and Primecap Management Co. CA (1.45%). Company insiders that own Agilent Technologies stock include Boon Hwee Koh, Didier Hirsch, Dominique Grau, Heidi Fields, Jacob Thaysen, James Cullen, Mark Doak, Michael R Mcmullen, Patrick G Hagan, Patrick Kaltenbach, Paul N Clark and Rodney Gonsalves. View Institutional Ownership Trends for Agilent Technologies.
Which institutional investors are selling Agilent Technologies stock?
A stock was sold by a variety of institutional investors in the last quarter, including MERIAN GLOBAL INVESTORS UK Ltd, FMR LLC, Renaissance Technologies LLC, Victory Capital Management Inc., Marshall Wace North America L.P., BlackRock Inc., Putnam Investments LLC and Deutsche Bank AG. Company insiders that have sold Agilent Technologies company stock in the last year include Boon Hwee Koh, Dominique Grau, Heidi Fields, Mark Doak, Michael R Mcmullen, Patrick Kaltenbach, Paul N Clark and Rodney Gonsalves. View Insider Buying and Selling for Agilent Technologies.
Which institutional investors are buying Agilent Technologies stock?
A stock was purchased by a variety of institutional investors in the last quarter, including Marshall Wace LLP, Point72 Asset Management L.P., OppenheimerFunds Inc., American Century Companies Inc., Pictet Asset Management Ltd., MARSHALL WACE ASIA Ltd, Man Group plc and Redmile Group LLC. View Insider Buying and Selling for Agilent Technologies.
How do I buy shares of Agilent Technologies?
Shares of A can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Agilent Technologies' stock price today?
One share of A stock can currently be purchased for approximately $69.36.
How big of a company is Agilent Technologies?
Agilent Technologies has a market capitalization of $22.87 billion and generates $4.91 billion in revenue each year. The medical research company earns $316 million in net income (profit) each year or $2.79 on an earnings per share basis. Agilent Technologies employs 13,500 workers across the globe.
What is Agilent Technologies' official website?
How can I contact Agilent Technologies?
Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The medical research company can be reached via phone at 408-345-8886 or via email at [email protected]
MarketBeat Community Rating for Agilent Technologies (NYSE A)
MarketBeat's community ratings are surveys of what our community members think about Agilent Technologies and other stocks. Vote "Outperform" if you believe A will outperform the S&P 500 over the long term. Vote "Underperform" if you believe A will underperform the S&P 500 over the long term. You may vote once every thirty days.
